Article: Millipore Reports Third Quarter Earnings of $0.50 Per Share on 14 Percent Revenue Growth.

Business Editors/Health/Medical Writers

BILLERICA, Mass.--(BUSINESS WIRE)--Oct. 15, 2003

Millipore Corporation (NYSE/MIL) announced today that its third quarter sales were $200 million, up 14 percent from the same period last year. Sales growth in local currencies was 9 percent. Third quarter earnings from continuing operations were $0.50 per share which includes a $0.01 per share gain on the sale of real estate.

Fran Lunger, Millipore's Chairman, CEO and President, said: "Our third quarter revenue growth was a combination of 16 percent local currency growth in biotechnology and 5 percent local currency growth in both life sciences and other ...






Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!